Literature DB >> 25232455

Early termination of immune tolerance state of hepatitis B virus infection explains liver damage.

Sheikh Mohammad Fazle Akbar1, Helal Uddin1, Sakirul Islam Khan1, Salimur Rahman1.   

Abstract

AIM: To assess an early termination of immune tolerance state of chronic hepatitis B virus infection in Bangladesh and its clinical significance.
METHODS: From a series of 167 treatment-naive chronic hepatitis B patients aged between 12 to 20 years (mean ± SD; 17.5 ± 2.8 years), percutaneous liver biopsies of 89 patients who were all hepatitis B e antigen negative at presentation were done. Of them, 81 were included in the study. They had persistently normal or raised serum alanine aminotransferase (ALT) values. A precore mutation (PCM) study was accomplished in 8 patients who were randomly selected.
RESULTS: Forty-four (53.7%) patients had significant necroinflammation (HAI-NI > 7), while significant fibrosis (HAI-F ≥ 3) was seen in 15 (18.5%) patients. Serum ALT (cut off 42 U/L) was raised in 29 (35.8%) patients, while low HBV DNA load (< 10(5) copies/mL) was observed in 57 (70.4%) patients. PCM was negative in all 8 patients.
CONCLUSION: This study indicates that the current concept of age-related immune tolerance state of HBV infection deserves further analyses in different population groups.

Entities:  

Keywords:  Chronic hepatitis B; Early termination; Immune tolerance

Year:  2014        PMID: 25232455      PMCID: PMC4163745          DOI: 10.4254/wjh.v6.i8.621

Source DB:  PubMed          Journal:  World J Hepatol


  29 in total

1.  Replication capacities of natural and artificial precore stop codon mutants of hepatitis B virus: relevance of pregenome encapsidation signal.

Authors:  S P Tong; J S Li; L Vitvitski; C Trépo
Journal:  Virology       Date:  1992-11       Impact factor: 3.616

Review 2.  The molecular biology of the hepatitis B viruses.

Authors:  D Ganem; H E Varmus
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

3.  Chronic active hepatitis with hepatitis B virus DNA and antibody against e antigen in the serum. Disturbed synthesis and secretion of e antigen from hepatocytes due to a point mutation in the precore region.

Authors:  Y Akahane; T Yamanaka; H Suzuki; Y Sugai; F Tsuda; S Yotsumoto; S Omi; H Okamoto; Y Miyakawa; M Mayumi
Journal:  Gastroenterology       Date:  1990-10       Impact factor: 22.682

4.  Hepatitis B virus gene function: the precore region targets the core antigen to cellular membranes and causes the secretion of the e antigen.

Authors:  J H Ou; O Laub; W J Rutter
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

5.  Active-passive Immunization Effectiveness Against Hepatitis B Virus in Children Born to HBsAg Positive Mothers in Amol, North of Iran.

Authors:  Yousef Yahyapour; Mohammad Karimi; Hamid-Reza Molaei; Esmaeil Khoddami; Mahmoud Mahmoudi
Journal:  Oman Med J       Date:  2011-11

6.  Determination of serum hepatitis B virus DNA in chronic HBsAg carriers: clinical significance and correlation with serological markers.

Authors:  Kendal Yalçin; Halil Değertekin; M Nail Alp; Selahattin Tekeş; Omer Satici; Turgay Budak
Journal:  Turk J Gastroenterol       Date:  2003-09       Impact factor: 1.852

7.  Serological profile of incidentally detected asymptomatic HBsAg positive subjects (IDAHS).

Authors:  Nasir Khokhar; Muzaffar Lateef Gill
Journal:  J Coll Physicians Surg Pak       Date:  2004-04       Impact factor: 0.711

8.  Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection?

Authors:  George V Papatheodoridis; Emanuel K Manesis; Spilios Manolakopoulos; Ioannis S Elefsiniotis; John Goulis; John Giannousis; Antonios Bilalis; Georgia Kafiri; Dimitrios Tzourmakliotis; Athanasios J Archimandritis
Journal:  Hepatology       Date:  2008-11       Impact factor: 17.425

9.  Chronic hepatitis B virus carriers in the immunotolerant phase of infection: histologic findings and outcome.

Authors:  Tony Andreani; Lawrence Serfaty; Djamila Mohand; Salem Dernaika; Dominique Wendum; Olivier Chazouillères; Raoul Poupon
Journal:  Clin Gastroenterol Hepatol       Date:  2007-04-11       Impact factor: 11.382

10.  Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis.

Authors:  R G Knodell; K G Ishak; W C Black; T S Chen; R Craig; N Kaplowitz; T W Kiernan; J Wollman
Journal:  Hepatology       Date:  1981 Sep-Oct       Impact factor: 17.425

View more
  3 in total

Review 1.  Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission.

Authors:  Shiv K Sarin; Manoj Kumar; Mohammed Eslam; Jacob George; Mamun Al Mahtab; Sheikh M Fazle Akbar; Jidong Jia; Qiuju Tian; Rakesh Aggarwal; David H Muljono; Masao Omata; Yoshihiko Ooka; Kwang-Hyub Han; Hye Won Lee; Wasim Jafri; Amna S Butt; Chern H Chong; Seng G Lim; Raoh-Fang Pwu; Ding-Shinn Chen
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-12-15

2.  New horizon for radical cure of chronic hepatitis B virus infection.

Authors:  Kazuto Tajiri; Yukihiro Shimizu
Journal:  World J Hepatol       Date:  2016-07-28

Review 3.  Cost Assessment of Hepatitis B Virus-related Hepatitis in Bangladesh.

Authors:  Mamun Al Mahtab; Muntasir Chaudhury; Mohammad H Uddin; Sheikh M Noor-E Alam; Mohammad A Rahim; Mohammad A Alam; Ahmed L Moben; Faiz A Khondaker; Mohammad Fi Choudhury; Mohammad Ja Sarkar; Provat K Poddar; Syed A Foez; Sheikh Mf Akbar
Journal:  Euroasian J Hepatogastroenterol       Date:  2016-12-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.